≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    α
    ALPHA CARBON LABS
    Survodutide research peptide - high purity lyophilized powder for laboratory research

    10MG

    $200
    3ml Vial
    In Stock
    Bulk Discounts

    Buy 3+ for $190.00 each and save 5%

    Buy 5+ for $180.00 each and save 10%

    Buy 10+ for $170.00 each and save 15%

    This product is for research purposes only. Not for human consumption.

    Purity: >98% (HPLC verified)

    Formulation: Lyophilized powder

    Molecular Formula: C235H357N61O66S

    Molecular Weight: 5188.82 g/mol

    CAS Number: N/A

    PubChem CID: N/A

    Survodutide

    GLP-1 Agonists

    Overview

    Survodutide (BI 456906) is a peptide designed as a dual agonist for the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor (GCGR). It was developed to study the combined metabolic effects of activating both pathways.

    Mechanism of Action

    Survodutide functions as an agonist at two G-protein coupled receptors: the GLP-1 receptor and the glucagon receptor.

    Research Findings

    Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

    Research Applications

    • MASH research
    • NAFLD and steatohepatitis studies
    • Glycemic parameter studies
    • Liver fibrosis research
    • Hepatic steatosis and liver lipid metabolism studies
    • Dual GLP-1/glucagon receptor agonist mechanism research
    • Energy expenditure and thermogenesis research
    • Lipid metabolism research
    • Multi-receptor agonist peptide research
    • Liver histology studies

    Laboratory Handling & Limitations

    This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

    Laboratory Handling

    Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

    Research Limitations

    Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.

    Scientific References

    1. Sanyal, A. J., et al. (2023). A phase 2 randomized trial of survodutide in MASH and fibrosis. New England Journal of Medicine, 389(17), 1567-1579.
    2. Frias, J. P., et al. (2023). Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes. The Lancet, 401(10392), 1809-1821.

    Research Use Only

    This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.